Angiomax bivalirudin: Completed Phase IIIb trial enrollment

The Medicines Co. (MDCO), Cambridge, Mass.
Product: Angiomax bivalirudin
Business: Cardiovascular
Therapeutic

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE